Eisai unveiled findings on the experimental Alzheimer’s drug it's developing with Biogen that provide more tinder for the hot debate over whether the drug’s efficacy is worth risks that include serious brain bleeding. https://t.co/mIUdevGaRM— Bloomberg (@business) November 30, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


